BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu JK, Chen ZX, Zhou ZG, Zhang B, Tian J, Chen JP, Wang L, Wang CH, Chen HY, Li YP. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J Gastroenterol 2002; 8(6): 1023-1028 [PMID: 12439918 DOI: 10.3748/wjg.v8.i6.1023] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 He J, Xiong Y, Mo D, Tang M, Hashmi MF. Meta-Analysis of the Effect of Dietary Care on Nausea and Vomiting in Oncology Chemotherapy Patients. Contrast Media & Molecular Imaging 2022;2022:1-6. [DOI: 10.1155/2022/3163230] [Reference Citation Analysis]
2 Liang Y, Zhao L, Chen H, Lin T, Chen T, Zhao M, Hu Y, Yu J, Liu H, Li G. Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study. BMC Cancer 2021;21:196. [PMID: 33632161 DOI: 10.1186/s12885-021-07919-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li B, Chen L, Luo HL, Yi FM, Wei YP, Zhang WX. Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis. World J Clin Cases 2019; 7(5): 600-615 [PMID: 30863759 DOI: 10.12998/wjcc.v7.i5.600] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Manzini G, Henne-Bruns D, Kremer M. Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trials. BMJ Open Gastroenterol. 2017;4:e000138. [PMID: 29177062 DOI: 10.1136/bmjgast-2017-000138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Yu Z, Guo X, Jiang Y, Teng L, Luo J, Wang P, Liang Y, Zhang H. Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis. Breast Cancer 2018;25:8-16. [PMID: 28755088 DOI: 10.1007/s12282-017-0794-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang Y, Wang C, Xiao H, Niu C, Wu H, Jin H, Yao C, He H, Tian H, Han F, Li D, Han W, Xu J, Chen J, Cui J, Li W. Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer. Cancer Med 2017;6:45-53. [PMID: 27790867 DOI: 10.1002/cam4.942] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Quéro L, Guillerm S, Hennequin C. Neoadjuvant or adjuvant therapy for gastric cancer. World J Gastrointest Oncol 2015; 7(8): 102-110 [PMID: 26306142 DOI: 10.4251/wjgo.v7.i8.102] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
8 Freires IA, Denny C, Benso B, de Alencar SM, Rosalen PL. Antibacterial Activity of Essential Oils and Their Isolated Constituents against Cariogenic Bacteria: A Systematic Review. Molecules 2015;20:7329-58. [PMID: 25911964 DOI: 10.3390/molecules20047329] [Cited by in Crossref: 122] [Cited by in F6Publishing: 119] [Article Influence: 17.4] [Reference Citation Analysis]
9 Batista TP, Santos CA, Almeida GF. Perioperative chemotherapy in locally advanced gastric cancer. Arq Gastroenterol 2013;50:236-42. [PMID: 24322198 DOI: 10.1590/S0004-28032013000200042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
10 Diaz-Nieto R, Orti-Rodríguez R, Winslet M. Post-surgical chemotherapy versus surgery alone for resectable gastric cancer. Cochrane Database Syst Rev. 2013;9:CD008415. [PMID: 23999923 DOI: 10.1002/14651858.cd008415.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
11 Chen XL, Chen XZ, Yang C, Liao YB, Li H, Wang L, Yang K, Li K, Hu JK, Zhang B, Chen ZX, Chen JP, Zhou ZG. Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis. PLoS One. 2013;8:e60320. [PMID: 23593191 DOI: 10.1371/journal.pone.0060320] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
12 Dikken JL, Stiekema J, van de Velde CJ, Verheij M, Cats A, Wouters MW, van Sandick JW. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol 2013;20:381-98. [PMID: 23054104 DOI: 10.1245/s10434-012-2574-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
13 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
14 Dikken JL, Cats A, Verheij M, van de Velde CJ. Randomized trials and quality assurance in gastric cancer surgery: Randomized Trials and Quality Assurance. J Surg Oncol 2013;107:298-305. [DOI: 10.1002/jso.23080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Knight G, Earle CC, Cosby R, Coburn N, Youssef Y, Malthaner R, Wong RK; Gastrointestinal Cancer Disease Site Group. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. Gastric Cancer. 2013;16:28-40. [PMID: 22467061 DOI: 10.1007/s10120-012-0148-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
16 Freires I, Silva I, Alves L, Bezerra L, Castro R. Clinical applicability of natural product(s)-containing mouthwashes as adjunctive treatment of biofilm-induced gingivitis: a systematic review. Rev bras plantas med 2012;14:700-11. [DOI: 10.1590/s1516-05722012000400019] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Nakamura J, Kitajima Y, Kai K, Hashiguchi K, Hiraki M, Noshiro H, Miyazaki K. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy. Int J Cancer 2010;127:1158-71. [PMID: 20020496 DOI: 10.1002/ijc.25129] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
18 Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D’Ugo D. R0 resection in the treatment of gastric cancer: Room for improvement. World J Gastroenterol 2010; 16(27): 3358-3370 [PMID: 20632437 DOI: 10.3748/wjg.v16.i27.3358] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
19 Carlomagno C, Matano E, Bianco R, Cimminiello C, Prudente A, Pagliarulo C, Crispo A, Cannella L, DE Stefano A, D'Armiento FP, DE Placido S. Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors. Exp Ther Med 2010;1:611-7. [PMID: 22993584 DOI: 10.3892/etm_00000096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Critical Reviews in Oncology/Hematology 2009;71:127-64. [DOI: 10.1016/j.critrevonc.2009.01.004] [Cited by in Crossref: 266] [Cited by in F6Publishing: 262] [Article Influence: 20.5] [Reference Citation Analysis]
21 Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009;96:26-33. [PMID: 19016271 DOI: 10.1002/bjs.6408] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 5.4] [Reference Citation Analysis]
22 Barros-Silva JD, Leitão D, Afonso L, Vieira J, Dinis-Ribeiro M, Fragoso M, Bento MJ, Santos L, Ferreira P, Rêgo S, Brandão C, Carneiro F, Lopes C, Schmitt F, Teixeira MR. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer 2009;100:487-93. [PMID: 19156142 DOI: 10.1038/sj.bjc.6604885] [Cited by in Crossref: 107] [Cited by in F6Publishing: 111] [Article Influence: 8.2] [Reference Citation Analysis]
23 Oechsle K, Bokemeyer C, Hartmann JT, Budach W, Trarbach T, Stahl M, Boehlke I, Kollmannsberger C; German AIO/ARO/CAO group. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group. J Cancer Res Clin Oncol 2009;135:163-72. [PMID: 18825411 DOI: 10.1007/s00432-008-0463-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Jeung H, Rha SY, Shin SJ, Ahn JB, Roh JK, Park CH, Noh SH, Chung HC. Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials. Cancer Chemother Pharmacol 2009;63:919-27. [DOI: 10.1007/s00280-008-0808-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Zhao SL, Fang JY. The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis. Cancer Invest. 2008;26:317-325. [PMID: 18317973 DOI: 10.1080/07357900701834686] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
26 Jackson C, Starling N, Chua YJ, Cunningham D. Pharmacotherapy for oesophagogastric cancer. Drugs 2007;67:2539-56. [PMID: 18034590 DOI: 10.2165/00003495-200767170-00006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol 2007;46:277-85. [PMID: 17450463 DOI: 10.1080/02841860701218634] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
28 Coit D. Adjuvant Therapy for Gastric Cancer. Journal of the American College of Surgeons 2007;205:S54-8. [DOI: 10.1016/j.jamcollsurg.2007.06.329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Barone C, Basso M, Schinzari G, Pozzo C, Trigila N, D’Argento E, Quirino M, Astone A, Cassano A. Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer. Gastric Cancer. 2007;10:104-111. [PMID: 17577620 DOI: 10.1007/s10120-007-0415-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
30 Focan C, Kreutz F, Longrée L, Graas M, Moeneclaey N, Demolin G, Focan-henrard D. Intérêt de la chronothérapie dans le traitement pluridisciplinaire des cancers de l'œsophage et de l'estomac. Pathologie Biologie 2007;55:181-5. [DOI: 10.1016/j.patbio.2006.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Ajani J. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers. Cancer. 2006;107:221-231. [PMID: 16770784 DOI: 10.1002/cncr.21986] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
32 Nitti D, Wils J, Dos Santos JG, Fountzilas G, Conte PF, Sava C, Tres A, Coombes RC, Crivellari D, Marchet A. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann Oncol. 2006;17:262-269. [PMID: 16293676 DOI: 10.1093/annonc/mdj077] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
33 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2005;54:209-241. [PMID: 15890270 DOI: 10.1016/j.critrevonc.2005.01.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
34 Hundahl SA. Evidence-based recommendations for local-regional control of gastric cancer. Cancer Invest 2005;23:352-62. [PMID: 16100947 DOI: 10.1081/cnv-58885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Brigand C, Arvieux C, Gilly FN, Glehen O. Treatment of peritoneal carcinomatosis in gastric cancers. Dig Dis. 2004;22:366-373. [PMID: 15812161 DOI: 10.1159/000083600] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
36 Silberman H. Perioperative adjunctive treatment in the management of operable gastric cancer. J Surg Oncol 2005;90:174-86; discussion 186-7. [PMID: 15895444 DOI: 10.1002/jso.20226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
37 Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27-39. [PMID: 15621988 DOI: 10.1097/01.sla.0000149300.28588.23] [Cited by in Crossref: 405] [Cited by in F6Publishing: 383] [Article Influence: 23.8] [Reference Citation Analysis]
38 Zheng LD, Tong QS, Wang L, Liu J, Qian W. Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells. World J Gastroenterol 2005; 11(1): 79-83 [PMID: 15609401 DOI: 10.3748/wjg.v11.i1.79] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
39 Bouché O, Raoul JL, Bonnetain F, Giovannini M, Etienne PL, Lledo G, Arsène D, Paitel JF, Guérin-Meyer V, Mitry E. Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803. J Clin Oncol. 2004;22:4319-4328. [PMID: 15514373 DOI: 10.1200/jco.2004.01.140] [Cited by in Crossref: 196] [Cited by in F6Publishing: 63] [Article Influence: 10.9] [Reference Citation Analysis]
40 Zhang AP, Liu BH, Zhang LY, Wang YX, Xiong RP, Zhou P. An inhibitor of p53 protects intestinal epithelial cells against apoptosis induced by hyperthermic chemotherapy. Shijie Huaren Xiaohua Zazhi 2004; 12(10): 2353-2355 [DOI: 10.11569/wcjd.v12.i10.2353] [Reference Citation Analysis]
41 Fu G, Wang GB, Lu XM, Huang QX, Zheng H. MAPK signal transduction and apoptosis of human gastric carcinoma cells induced by liposomes of survivin antisense oligonucleotide. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1034-1039 [DOI: 10.11569/wcjd.v12.i5.1034] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Chen XM, Chen GY, Wang ZR, Zhu FS, Wang XL, Zhang X. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol 2004; 10(6): 804-808 [PMID: 15040021 DOI: 10.3748/wjg.v10.i6.804] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
43 Ma T, Zhu ZG, Ji YB, Zhang Y, Yu YY, Liu BY, Yin HR, Lin YZ. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2’-deoxyuridine. World J Gastroenterol 2004; 10(2): 172-176 [PMID: 14716816 DOI: 10.3748/wjg.v10.i2.172] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 17] [Article Influence: 0.2] [Reference Citation Analysis]
44 Lin WL, Li DG, Chen Q, Lu HM, Ma XM, Sun PL. Clinical efficacy and mechanism of oxaliplatin in treating human gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2003; 11(10): 1535-1539 [DOI: 10.11569/wcjd.v11.i10.1535] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Han ZY, Wu KC, He FT, Han QL, Nie YZ, Han Y, Liu XN, Zheng JY, Xu MH, Lin T, Fan DM. Screening and identification of mimotope of gastric cancer associated antigen MGb1-Ag. World J Gastroenterol 2003; 9(9): 1920-1924 [PMID: 12970876 DOI: 10.3748/wjg.v9.i9.1920] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]